Today's Paper Latest Elections Coronavirus 🔵 Covid Classroom Cooking Families Core values Story ideas iPad Weather Newsletters Obits Puzzles Archive
story.lead_photo.caption FILE - In this Oct. 14, 2020 file photo, the American Flag hangs outside the New York Stock Exchange in New York. U.S. stocks are drifting close to their record highs Wednesday, Nov. 18 as hopes for a coronavirus vaccine coming in the future collide with worries about the worsening pandemic in the present. The S&P 500 was 0.1% lower in early trading after flipping between small gains and losses. (AP Photo/Frank Franklin II, File)

A late-afternoon slide on Wall Street dragged stocks broadly lower Wednesday, wiping out early gains and adding to losses from a day earlier as investors worry about the economic fallout from surging coronavirus cases in the U.S.

The S&P 500 fell 1.16%. It had been up 0.3% in the early going after Pfizer and BioNTech reported updated data suggesting their potential covid-19 vaccine may be 95% effective. The companies said they plan to ask U.S. regulators within days to allow emergency use of the vaccine.

The news, which followed encouraging data on Monday about a vaccine being developed by Moderna, initially gave investors cause for optimism that the virus-ravaged economy could begin to heal next year. But such optimism is being tempered by a spike in coronavirus cases and worries that it will lead to widespread restrictions on businesses once more.

The S&P 500 fell 41.74 points to 3,567.79. The Dow Jones Industrial Average dropped 344.93 points, or 1.16%, to 29,438.42. The Nasdaq composite lost 97.74 points, or 0.8%, to 11,801.60.

[CORONAVIRUS: Click here for our complete coverage »]

Small-company stocks, which have notched the biggest gains this month, gave up 22.60 points, or 1.3%, to 1,769.32.

Coronavirus counts and hospitalizations are up across the country, and health experts are warning about the possibility of a brutal winter.

"This is a market that is fluctuating as it makes a determination about the effect that the covid-19 restrictions and lockdowns have on the reopening of the U.S. economy, versus the positive news that stems from potential vaccinations beginning in 2021," said Quincy Krosby, chief market strategist at Prudential Financial. "It's sort of a tug of war."

Newly confirmed coronavirus infections per day in the U.S. have exploded over the past two weeks to the highest levels on record, with the daily count running at close to 160,000 on average. Cases are on the rise in all 50 states.

The surge is leading governors and mayors across the U.S. to grudgingly issue mask mandates, limit the size of private and public gatherings, ban indoor restaurant dining, close gyms or restrict the hours and capacity of various businesses. Wednesday's afternoon sell-off on Wall Street accelerated after New York City said it would close its public schools to in-person learning again as infections continue to rise there.

Despite shedding modest gains from earlier in the day, stocks remain close to their record highs. Hopes for a coronavirus vaccine coming in the future have helped push stocks higher this month as some investors look past the worsening pandemic in the present.

"That story seems to be moderating a little bit here as the coronavirus news has now mostly been digested by the marketplace," said Tom Martin, senior portfolio manager with Globalt Investments. "The vaccine news immediately captures the imagination because you see an endpoint."

Companies that would benefit most from a healing, reopening economy, such as airlines and banks, helped push the market higher in the early going Wednesday, though the stocks gave up much of their gains by the end of the day. United Airlines gained 1.1% and American Airlines added 0.3%.

All told, technology, health care and communication services stocks accounted for much of the decline.

Many risks remain for the market. Chief among them is the pandemic, which is accelerating so quickly that governments across the United States and Europe are bringing back varying degrees of restrictions on businesses.

Even with the encouraging figures from pharmaceutical companies about their potential vaccines, there's also still no guarantee one will be approved or how long it will take for it to be widely distributed.

The yield on the 10-year Treasury ticked up to 0.87% from 0.85% late Tuesday. A report showed that homebuilders broke ground on more new houses last month than economists expected.

Information for this article was contributed by Joe McDonald of The Associated Press.


Sponsor Content

COMMENTS - It looks like you're using Internet Explorer, which isn't compatible with the Democrat-Gazette commenting system. You can join the discussion by using another browser, like Firefox or Google Chrome.
It looks like you're using Microsoft Edge. The Democrat-Gazette commenting system is more compatible with Firefox and Google Chrome.